Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Joseph L Chin
Affiliation
University of Western Ontario
ORCID
Career Start Year
1982
Papers
317
H Index
51
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37838556
Magnetic Resonance Imaging-Targeted Versus Systematic Prostate Biopsies: 2-year Follow-up of a Prospective Randomized Trial (PRECISE).
Eur Urol Oncol
2024
37439809
Neoadjuvant Cabazitaxel plus Abiraterone/Leuprolide Acetate in Patients with High-Risk Prostate Cancer: ACDC-RP Phase II Trial.
Clin Cancer Res
2023
37494316
Genetic testing practices among specialist physicians who treat prostate cancer A Canadian, cross-sectional survey.
Can Urol Assoc J
2023
37126232
Multimodal Biomarkers That Predict the Presence of Gleason Pattern 4: Potential Impact for Active Surveillance.
J Urol
2023
37081426
The use of Lutetium-177 PSMA radioligand therapy with high dose rate brachytherapy for locally recurrent prostate cancer after previous definitive radiation therapy: a randomized, single-institution, phase I/II study (ROADSTER).
BMC Cancer
2023
34812728
Metastatic progression following multimodal therapy for unfavorable-risk prostate cancer.
Can Urol Assoc J
2022
35668135
The metabolic enzyme hexokinase 2 localizes to the nucleus in AML and normal haematopoietic stem and progenitor cells to maintain stemness.
Nat Cell Biol
2022
35358408
QUEST at 25: An enduring innovation in Canadian urology.
Can Urol Assoc J
2022
36656699
Artificial intelligence for prostate cancer histopathology diagnostics.
Can Urol Assoc J
2022
36095953
Prostate cancer classification using radiomics and machine learning on mp-MRI validated using co-registered histology.
Eur J Radiol
2022
35076300
Effect of <sup>18</sup>F-DCFPyL PET/CT on the Management of Patients with Recurrent Prostate Cancer: Results of a Prospective Multicenter Registry Trial.
Radiology
2022
34978211
Low Serum Testosterone in Men with Newly Diagnosed Androgen-Deprivation Therapy-Naïve Prostate Cancer and Its Relationship to Cardiovascular Risk Factors: A RADICAL-PC Substudy.
J Urol
2022
35337747
Targeting prostate lesions on multiparametric MRI with HDR brachytherapy: Optimal planning margins determined using whole-mount digital histology.
Brachytherapy
2022
32814843
Long-term outcomes of two ablation techniques for treatment of radio-recurrent prostate cancer.
Prostate Cancer Prostatic Dis
2021
33716036
A Randomized Controlled Trial of a Modified Cystoscopy Technique using the Peak-End Rule in order to Improve Pain and Anxiety.
Urology
2021
33648893
A multiobserver study investigating the effectiveness of prostatic multiparametric magnetic resonance imaging to dose escalate corresponding histologic lesions using high-dose-rate brachytherapy.
Brachytherapy
2021
34589619
Prostate specific membrane antigen positron emission tomography for lesion-directed high-dose-rate brachytherapy dose escalation.
Phys Imaging Radiat Oncol
2021
34584809
Characterizing Surgical and Radiotherapy Outcomes in Non-metastatic High-Risk Prostate Cancer: A Systematic Review and Meta-Analysis.
Cureus
2021
34400038
Multiparametric Magnetic Resonance Imaging in the Diagnosis of Clinically Significant Prostate Cancer: an Updated Systematic Review.
Clin Oncol (R Coll Radiol)
2021
34652551
Short-duration dynamic [<sup>18</sup>F]DCFPyL PET and CT perfusion imaging to localize dominant intraprostatic lesions in prostate cancer: validation against digital histopathology and comparison to [<sup>18</sup>F]DCFPyL PET/MR at 120 minutes.
EJNMMI Res
2021
33253070
Editorial Comment.
J Urol
2021
33394284
Kinetic analysis of dominant intraprostatic lesion of prostate cancer using quantitative dynamic [<sup>18</sup>F]DCFPyL-PET: comparison to [<sup>18</sup>F]fluorocholine-PET.
EJNMMI Res
2021
33234494
Cognition and depression effects of androgen receptor axis-targeted drugs in men with prostate cancer: A systematic review.
J Geriatr Oncol
2021
33410740
Longitudinal experience with Studer neobladders: Outcomes and complications.
Can Urol Assoc J
2021
33007180
Does adding local salvage ablation therapy provide survival advantage for patients with locally recurrent prostate cancer following radiotherapy? Whole gland salvage ablation post-radiation failure in prostate cancer.
Can Urol Assoc J
2021
32935575
Relief of Lower Urinary Tract Symptoms After MRI-Guided Transurethral Ultrasound Ablation for Localized Prostate Cancer: Subgroup Analyses in Patients with Concurrent Cancer and Benign Prostatic Hyperplasia.
J Endourol
2021
32453694
Continuing towards optimization of bladder cancer care in Canada: Summary of the third Bladder Cancer Canada-Canadian Urological Association-Canadian Urologic Oncology Group (BCC-CUA-CUOG) bladder cancer quality of care consensus meeting.
Can Urol Assoc J
2020
33704177
Primary Mediastinal Germ Cell Tumors-The University of Western Ontario Experience.
Curr Oncol
2020
31899651
Cardiovascular Risk in Men with Prostate Cancer: Insights from the RADICAL PC Study.
J Urol
2020
31926754
The Singularity is Near(ish): Emerging Applications of Artificial Intelligence in Prostate Cancer Management.
Eur Urol
2020
32717361
Is prostate brachytherapy a dying art? Trends and variation in the definitive management of prostate cancer in Ontario, Canada.
Radiother Oncol
2020
32605858
Re: Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review.
Eur Urol
2020
32715024
Automatic cancer detection on digital histopathology images of mid-gland radical prostatectomy specimens.
J Med Imaging (Bellingham)
2020
32827589
Histologic validation of auto-contoured dominant intraprostatic lesions on [<sup>18</sup>F] DCFPyL PSMA-PET imaging.
Radiother Oncol
2020
32680677
Small Renal Mass Surveillance: Histology-specific Growth Rates in a Biopsy-characterized Cohort.
Eur Urol
2020
32218666
Complex surgery and perioperative systemic therapy for genitourinary cancer of the retroperitoneum.
Curr Oncol
2020
32555410
Histologic tissue components provide major cues for machine learning-based prostate cancer detection and grading on prostatectomy specimens.
Sci Rep
2020
32391232
Cryosurgery Versus Primary Androgen Deprivation Therapy for Locally Recurrent Prostate Cancer After Primary Radiotherapy: A Propensity-Matched Survival Analysis.
Cureus
2020
32308085
Salvage open radical prostatectomy for recurrent prostate cancer following MRI-guided transurethral ultrasound ablation (TULSA) of the prostate: feasibility and efficacy.
Scand J Urol
2020
32569569
The history of renal transplantation in Canada: A urologic perspective.
Can Urol Assoc J
2020
32569568
Real-world evidence in patient-reported outcomes (PROs) of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate + prednisone (AA+P) across Canada: Final results of COSMiC.
Can Urol Assoc J
2020
30430700
Characterization of clinical human prostate cancer lesions using 3.0-T sodium MRI registered to Gleason-graded whole-mount histopathology.
J Magn Reson Imaging
2019
32280821
Dosimetric Evaluation of PSMA PET-Delineated Dominant Intraprostatic Lesion Simultaneous Infield Boosts.
Adv Radiat Oncol
2019
30017404
Active Surveillance Magnetic Resonance Imaging Study (ASIST): Results of a Randomized Multicenter Prospective Trial.
Eur Urol
2019
31524572
Editorial Comment.
J Urol
2019
31433512
A three-gene DNA methylation biomarker accurately classifies early stage prostate cancer.
Prostate
2019
28583310
Robotic-assisted Radical Prostatectomy for High-risk Cancer: Time for "Sexta-fecta".
Eur Urol
2018
30070154
Editorial Comment on: Focal Treatment for Unilateral Prostate Cancer Using High-Intensity Focal Ultrasound: A Comprehensive Study of Pooled Data by Albisinni et al.
J Endourol
2018
29875044
Chronic renal pain: An approach to investigation and management.
Can Urol Assoc J
2018
29381462
Next-generation prostate cancer risk calculator for primary care physicians.
Can Urol Assoc J
2018
1 - 50 of 317
Column Actions
Search
Recommended Authors
Devin N Patel
university of california san diego School of Medicine
Career Start Year
2011
Number of shared co-authors
1
Izak Faiena
Columbia University Medical Center
Career Start Year
2010
Number of shared co-authors
0
Jure Murgic
University Hospital Center Sestre Milosrdnice
Career Start Year
2008
Number of shared co-authors
9
Adam Kinnaird
University of Alberta
Career Start Year
2007
Number of shared co-authors
4
Jonathan L Wright
University of Washington Medical Center
Career Start Year
2005
Number of shared co-authors
8
Declan G Murphy
Peter MacCallum Cancer Centre, University of Melbourne
Career Start Year
2005
Number of shared co-authors
12
Amirali Salmasi
University of California San Diego
Career Start Year
2005
Number of shared co-authors
1
Jun Hyuk Hong
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year
2002
Number of shared co-authors
1
Tim Dudderidge
University Hospital Southampton NHS Foundation Trust
Career Start Year
2002
Number of shared co-authors
3
Todd M Morgan
University of Michigan ann arbor
Career Start Year
1997
Number of shared co-authors
18
Niall M Corcoran
Royal Melbourne Hospital, The University of Melbourne
Career Start Year
1997
Number of shared co-authors
11
Alan Thompson
The Royal Marsden NHS Foundation Trust
Career Start Year
1996
Number of shared co-authors
2
Omer Acar
University of Illinois at Chicago
Career Start Year
1996
Number of shared co-authors
0
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year
1994
Number of shared co-authors
6
Douglas S Scherr
New York-Presbyterian Hospital
Career Start Year
1994
Number of shared co-authors
11
William Robert Lee
Duke University School of Medicine
Career Start Year
1993
Number of shared co-authors
9
Choung-Soo Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year
1993
Number of shared co-authors
4
Raymond S Lance
Washington State University Elson S. Floyd College of Medicine
Career Start Year
1992
Number of shared co-authors
9
Nicolas Mottet
Hospitalier Universitaire de Saint-Etienne
Career Start Year
1989
Number of shared co-authors
10
Christopher P Evans
University of California Davis
Career Start Year
1988
Number of shared co-authors
18
Mark Frydenberg
Monash University
Career Start Year
1988
Number of shared co-authors
14
Philip Cornford
Liverpool University Hospitals
Career Start Year
1988
Number of shared co-authors
3
Damien Bolton
University of Melbourne
Career Start Year
1988
Number of shared co-authors
8
Freddie C Hamdy
University of Oxford
Career Start Year
1987
Number of shared co-authors
12
Theo M de Reijke
Amsterdam University Medical Centers, University of Amsterdam
Career Start Year
1987
Number of shared co-authors
10
Arnulf Stenzl
Eberhard Karls University of Tubingen
Career Start Year
1984
Number of shared co-authors
10
Bruce J Trock
Johns Hopkins University School of Medicine
Career Start Year
1984
Number of shared co-authors
15
David E Neal
University of Oxford, John Radcliffe Hospital
Career Start Year
1981
Number of shared co-authors
19
Anthony J Costello
Royal Melbourne Hospital
Career Start Year
1974
Number of shared co-authors
11
Hartwig Huland
Martini-Klinik Prostate Cancer Center, University Hospital-Hamburg-Eppendorf
Career Start Year
1971
Number of shared co-authors
10
row(s) 1 - 30 of 30
Collaborators
Madeleine Moussa
Schulich School of Medicine and Dentistry, University of Western Ontario
Co-authored papers
44
Glenn Bauman
Western University and London Regional Cancer Program
Co-authored papers
35
Fred Saad
University of Montreal Health Center
Co-authored papers
26
Yves Fradet
CHU de Quebec-Universite Laval
Co-authored papers
26
Louis Lacombe
CHU de Quebec-Universite Laval
Co-authored papers
24
Neil E Fleshner
University of Toronto
Co-authored papers
16
Armen Aprikian
McGill University Health Centre, McGill University
Co-authored papers
16
Eric Winquist
Schulich School of Medicine and Dentistry, University of Western Ontario
Co-authored papers
13
David Robert Siemens
Queen's University
Co-authored papers
13
Andrew Loblaw
Princess Margaret Hospital, University of Toronto
Co-authored papers
12
Masoom A Haider
University Health Network
Co-authored papers
10
Martin E Gleave
University of British Columbia
Co-authored papers
8
Antonio Finelli
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Co-authored papers
8
Shiva M Nair
University of Western Ontario
Co-authored papers
7
Andrew J Evans
Princess Margaret Cancer Center, University Health Network.
Co-authored papers
7
John Trachtenberg
University of Toronto, University Health Network
Co-authored papers
6
Fadi Brimo
McGill University Health Centre, McGill University
Co-authored papers
5
Ian M Thompson
CHRISTUS Santa Rosa Hospital-Medical Center
Co-authored papers
5
Irina Rachinsky
University of Western Ontario
Co-authored papers
5
Girish S Kulkarni
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers
4
Michael Brundage
Cancer Centre of Southeastern Ontario
Co-authored papers
4
James Koropatnick
Western University, Lawson Health Research Institute
Co-authored papers
4
Emily D Crawford
Co-authored papers
4
Robert Bartha
The University of Western Ontario
Co-authored papers
3
Hon S Leong
University of Toronto
Co-authored papers
3
Alexandre R Zlotta
University Health Network, Princess Margaret Cancer Center, University of Toronto
Co-authored papers
3
Marshall Scott Lucia
University of Colorado School of Medicine
Co-authored papers
3
John R Srigley
University of Toronto
Co-authored papers
3
Kim N Chi
University of British Columbia
Co-authored papers
3
Andrew Warner
Western University and London Regional Cancer Program
Co-authored papers
3
1 - 30